• 1669 Citations
  • 20 h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mimi I-Nan Hu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Thyroid Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hypercalcemia Medicine & Life Sciences
Diphosphonates Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mutation Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Genetic profiling as a clinical tool in advanced parathyroid carcinoma

Kutahyalioglu, M., Nguyen, H. T., Kwatampora, L., Clarke, C., Silva Figueroa, A. M., Ibrahim, E., Waguespack, S. G., Cabanillas, M. E., Jimenez, C., Hu, M. I-N., Sherman, S. I., Kopetz, S., Broaddus, R., Dadu, R., Wanland, K., Williams, M. D., Zafereo, M., Perrier, N. D. & Busaidy, N. L., Aug 1 2019, In : Journal of cancer research and clinical oncology. 145, 8, p. 1977-1986 10 p.

Research output: Contribution to journalArticle

Parathyroid Neoplasms
Genes
Neoplasms
Mutation
Phosphatidylinositol 3-Kinases

Novel use of a CLIA-certified CDKN2C loss assay in sporadic medullary thyroid carcinoma

Maxwell, J. E., Gule-Monroe, M. K., Subbiah, V., Hu, M., Perrier, N. D., Cabanillas, M. E., Lee, J. E., Graham, P. H., Cote, G. J., Busaidy, N. L. & Grubbs, E. G., Jan 1 2019, (Accepted/In press) In : Surgery (United States).

Research output: Contribution to journalArticle

Therapeutics
Haploinsufficiency
Cyclin-Dependent Kinases
Retinoblastoma
Medullary Thyroid cancer
2 Citations (Scopus)

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W. J., Javle, M., Patel, S. P., Hu, M. I., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 others, Kim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Mitogen-Activated Protein Kinase Kinases
Neoplasms
1 Citation (Scopus)

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Hu, M. I-N., Elisei, R., Dedecjus, M., Popovtzer, A., Druce, M., Kapiteijn, E., Pacini, F., Locati, L., Krajewska, J., Weiss, R. & Gagel, R. F., Feb 1 2019, In : Endocrine-Related Cancer. 26, 2, p. 241-250 10 p.

Research output: Contribution to journalArticle

Safety
Asthenia
Hypokalemia
Hypocalcemia
Random Allocation

Vandetanib photoinduced cutaneous toxicities

Doan, H. Q., Hu, M. I-N., Goldstein, J. B., Piha-Paul, S. A., Subbiah, V. & Patel, A., Jan 1 2019, In : Cutis. 103, 5, p. E24-E29

Research output: Contribution to journalArticle

Skin
Vascular Endothelial Growth Factor Receptor
Solar System
Exanthema
Epidermal Growth Factor Receptor